发明名称 |
Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes |
摘要 |
The present invention relates to a new use for compounds having 5-HT3 (serotonin M) receptor antagonist activity, especially tropisetron, for the manufacture of a pharmaceutical composition for the systemic treatment of an inflammatory rheumatic or rheumatoid disease other than crystal induced arthritis and other than living pathogen induced inflammatory diseases as long as the living pathogen is still present. |
申请公布号 |
AU2672500(A) |
申请公布日期 |
2000.09.04 |
申请号 |
AU20000026725 |
申请日期 |
2000.02.16 |
申请人 |
NOVARTIS AG |
发明人 |
WOLFGANG MULLER;THOMAS STRATZ |
分类号 |
C07D233/64;A61K31/00;A61K31/417;A61K31/4178;A61K31/4184;A61K31/436;A61K31/437;A61K31/439;A61K45/00;A61K45/06;A61P19/00;A61P29/00;A61P43/00;C07D403/06;C07D451/12;C07D471/04;C07D471/08 |
主分类号 |
C07D233/64 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|